Evaluation of the antibacterial and inhibitory activity of the MepA efflux pump of Staphylococcus aureus by riparins I, II, III, and IV
Archives of Biochemistry and Biophysics · 2023-10 · 748 · 109782
DOI: 10.1016/j.abb.2023.109782 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2023-10. Verfasst von Cristina Rodrigues Dos Santos Barbosa und 17 weiteren Autor:innen. Beteiligte Einrichtung: Biological Chemistry, Department of Biological Chemistry, Cariri Regional University (URCA), Crato, CE, Brazil. Electronic address: cristinase75@gmai…. Hauptthemen laut MEDLINE: Staphylococcus aureus, Chlorpromazine. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 95 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação Cearense de Apoio ao Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
The efflux pump mechanism contributes to the antibiotic resistance of widely distributed strains of Staphylococcus aureus. Therefore, in the present work, the ability of the riparins N-(4-methoxyphenethyl)benzamide (I), 2-hydroxy-N-[2-(4-methoxyphenyl)ethyl]benzamide (II), 2, 6-dihydroxy-N-[ 2-(4-methoxyphenyl)ethyl]benzamide (III), and 3,4,5-trimethoxy-N-[2-(4-methoxyphenethyl)benzamide (IV) as potential inhibitors of the MepA efflux pump in S. aureus K2068 (fluoroquinolone-resistant). In addition, we performed checkerboard assays to obtain more information about the activity of riparins as potential inhibitors of MepA efflux and also analyzed the ability of riparins to act on the permeability of the bacterial membrane of S. aureus by the fluorescence method with SYTOX Green. A molecular coupling assay was performed to characterize the interaction between riparins and MepA, and ADMET (absorption, distribution, metabolism, and excretion) properties were analyzed. We observed that I-IV riparins did not show direct antibacterial activity against S. aureus. However, combination assays with substrates of MepA, ciprofloxacin, and ethidium bromide (EtBr) revealed a potentiation of the efficacy of these substrates by reducing the minimum inhibitory concentration (MIC). Furthermore, increased EtBr fluorescence emission was observed for all riparins. The checkerboard assay showed synergism between riparins I, II, and III, ciprofloxacin, and EtBr. Furthermore, riparins III and IV exhibited permeability in the S. aureus membrane at a concentration of 200 μg/mL. Molecular docking showed that riparins I, II, and III bound in a different region from the binding site of chlorpromazine (standard pump inhibitor), indicating a possible synergistic effect with the reference inhibitor. In contrast, riparin IV binds in the same region as the chlorpromazine binding site. From the in silico ADMET prediction based on MPO, it could be concluded that the molecules of riparin I-IV present their physicochemical properties within the ideal pharmacological spectrum allowing their preparation as an oral drug. Furthermore, the prediction of cytotoxicity in liver cell lines showed a low cytotoxic effect for riparins I-IV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biological Chemistry, Department of Biological Chemistry, Cariri Regional University (URCA), Crato, CE, Brazil. Electronic address: cristinase75@gmail.com.
- Biological Chemistry, Department of Biological Chemistry, Cariri Regional University (URCA), Crato, CE, Brazil. Electronic address: naiirmacedo@gmail.com.
- Biological Chemistry, Department of Biological Chemistry, Cariri Regional University (URCA), Crato, CE, Brazil. Electronic address: zildenesousa15@gmail.com.
- Biological Chemistry, Department of Biological Chemistry, Cariri Regional University (URCA), Crato, CE, Brazil. Electronic address: janainaesmeraldo@gmail.com.
- Biological Chemistry, Department of Biological Chemistry, Cariri Regional University (URCA), Crato, CE, Brazil. Electronic address: thiagocrato@hotmail.com.
- Biological Chemistry, Department of Biological Chemistry, Cariri Regional University (URCA), Crato, CE, Brazil. Electronic address: deehmuniz78@gmail.com.
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação Cearense de Apoio ao Desenvolvimento Científico e Tecnológico
- Pfizer
Zitieren
APA
Rodrigues Dos Santos Barbosa, C., Macêdo, N. S., de Sousa Silveira, Z., Rocha, J. E., Freitas, T. S., Muniz, D. F., Araújo, I. M., Datiane de Morais Oliveira-Tintino, C., Marinho, E. S., Nunes da Rocha, M., Marinho, M. M., Bezerra, A. H., Ribeiro de Sousa, G., Barbosa-Filho, J. M., de Souza-Ferrari, J., Melo Coutinho, H. D., Silva Dos Santos, H., & Bezerra da Cunha, F. A. (2023). Evaluation of the antibacterial and inhibitory activity of the MepA efflux pump of Staphylococcus aureus by riparins I, II, III, and IV. Archives of Biochemistry and Biophysics, 748, 109782. https://doi.org/10.1016/j.abb.2023.109782
Vancouver
Rodrigues Dos Santos Barbosa C, Macêdo NS, de Sousa Silveira Z, Rocha JE, Freitas TS, Muniz DF, et al. Evaluation of the antibacterial and inhibitory activity of the MepA efflux pump of Staphylococcus aureus by riparins I, II, III, and IV. Archives of Biochemistry and Biophysics. 2023;748:109782. doi:10.1016/j.abb.2023.109782
BibTeX
@article{RodriguesDosSantosBarbosa2023,
author = {Rodrigues Dos Santos Barbosa, Cristina and Macêdo, Nair Silva and de Sousa Silveira, Zildene and Rocha, Janaína Esmeraldo and Freitas, Thiago Sampaio and Muniz, Débora Feitosa and Araújo, Isaac Moura and Datiane de Morais Oliveira-Tintino, Cícera and Marinho, Emmanuel Silva and Nunes da Rocha, Matheus and Marinho, Marcia Machado and Bezerra, Antonio Henrique and Ribeiro de Sousa, Gabriela and Barbosa-Filho, José Maria and de Souza-Ferrari, Jailton and Melo Coutinho, Henrique Douglas and Silva Dos Santos, Hélcio and Bezerra da Cunha, Francisco Assis},
title = {Evaluation of the antibacterial and inhibitory activity of the MepA efflux pump of Staphylococcus aureus by riparins I, II, III, and IV},
journal = {Archives of Biochemistry and Biophysics},
year = {2023},
volume = {748},
pages = {109782},
doi = {10.1016/j.abb.2023.109782}
}
EUVIMED